06/18/2026
๐๐จ๐ฌ๐ญ ๐ก๐๐๐ฅ๐ญ๐ก๐ญ๐๐๐ก ๐๐จ๐ฎ๐ง๐๐๐ซ๐ฌ ๐ญ๐ก๐ข๐ง๐ค ๐ซ๐ข๐ฌ๐ค ๐ฆ๐๐๐ง๐ฌ ๐ซ๐ฎ๐ง๐ง๐ข๐ง๐ ๐จ๐ฎ๐ญ ๐จ๐ ๐๐๐ฌ๐ก.
But one of the biggest risks is actually emotional decision-making.
In my conversation with John De Goey, he shared something that stuck with me:
Many professionals giving financial advice are still chasing trends, concentrated positions, and hype
Not because they are trying to mislead people, but because they genuinely believe it is the right thing to do.
That same pattern shows up in startups all the time.
Founders overbuild products before validating demand.
Investors chase AI trends without understanding adoption risk.
Teams scale before proving the product is even sellable.
Thatโs why I kept asking during the episode:
โ๐๐ด ๐ต๐ฉ๐ช๐ด ๐ฆ๐ท๐ฆ๐ฏ ๐ด๐ฆ๐ญ๐ญ๐ข๐ฃ๐ญ๐ฆ ๐ฃ๐ฆ๐ง๐ฐ๐ณ๐ฆ ๐ธ๐ฆ ๐ต๐ข๐ญ๐ฌ ๐ข๐ฃ๐ฐ๐ถ๐ต ๐ด๐ค๐ข๐ญ๐ช๐ฏ๐จ?โ
Healthtech especially is not a fast game.
Long sales cycles.
Clinical validation.
Regulatory complexity.
Enterprise adoption.
You cannot afford emotionally reactive decision-making.
The founders who last are usually the ones who stay disciplined when everyone else is chasing momentum.
Question for founders:
๐๐ก๐๐ญโ๐ฌ ๐จ๐ง๐ ๐๐ข๐ง๐๐ง๐๐ข๐๐ฅ ๐จ๐ซ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐๐๐๐ข๐ฌ๐ข๐จ๐ง ๐ฒ๐จ๐ฎ ๐ฆ๐๐๐ ๐๐๐๐๐ฎ๐ฌ๐ ๐จ๐ ๐ฉ๐ซ๐๐ฌ๐ฌ๐ฎ๐ซ๐ ๐ข๐ง๐ฌ๐ญ๐๐๐ ๐จ๐ ๐๐๐ญ๐ฎ๐๐ฅ ๐ฌ๐ญ๐ซ๐๐ญ๐๐ ๐ฒ?